VRTX Operating Expenses

Vertex Pharmaceuticals · Operating Expenses

VRTX logo

VRTX Operating Expenses

Latest reported$5.99B
VRTX TTM Operating Expenses (-$6.40M → $5.99B)
High-resolution chart · PNG

VRTX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
5,989,900,000
5,798,200,000
6,119,300,000
6,121,200,000
5,908,800,000
10,291,100,000
9,722,500,000
9,421,100,000
9,283,600,000
4,654,000,000
4,774,400,000
4,599,100,000
4,391,800,000
4,061,100,000
3,543,000,000
3,506,600,000
3,280,340,000
4,055,540,000
3,892,790,000
3,621,717,000
3,607,825,000
2,626,457,000
2,609,193,000
2,606,054,000
2,643,628,000
2,557,289,000
2,413,038,000
2,328,841,000
2,081,024,000
2,020,266,000
1,974,092,000
1,824,459,000
1,932,311,000
1,874,176,000
1,820,704,000
1,737,606,000
1,543,374,000
1,509,334,000
1,483,519,000
1,532,642,000
1,497,273,000
1,432,865,000
1,373,250,000
1,245,757,000
1,165,864,000
1,149,838,000
1,161,554,000
1,206,361,000
1,256,569,000
1,283,319,000
1,281,118,000
1,279,882,000
1,261,356,000
1,246,438,000
1,242,981,000
1,227,739,000
1,229,600,000
1,185,809,000
1,108,427,000
1,031,474,000
951,057,000
876,787,000
825,216,000
761,654,000
711,069,000
686,929,000
680,466,000
681,480,000
669,934,000
654,098,000
618,202,000
588,176,000
581,383,000
584,871,000
597,781,000
583,973,000
544,496,000
490,607,000
429,573,000
385,558,000
348,998,000
313,549,000
292,530,000
277,465,000
262,527,000
249,966,000
234,301,000
291,306,000
291,474,000
338,909,000
287,400,000
235,338,000
239,330,000
194,179,000
252,408,000
236,579,000
223,136,000
201,212,000
176,710,000
148,435,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.